Latest News
Via The Motley Fool · April 2, 2025
Today, dubbed "Liberation Day" by President Donald Trump, marks the official rollout of his long-anticipated tariff policy, set to reshape U.S. trade with major partners like Canada, Mexico, and China. As the tariffs take effect, Wall Street is reacting with a mix of volatility and opportunity, with investors scrambling
Via MarketMinute · April 2, 2025
April 2, 2025 – Tesla, Inc. (NQ:TSLA) shares fell sharply in morning trading today after the electric vehicle giant reported first-quarter vehicle deliveries that significantly undershot Wall Street expectations. At 11:14:02 AM EDT, Tesla’s stock price stood at $265.62, reflecting a decline of $2.84, or
Via MarketMinute · April 2, 2025
Via Benzinga · April 2, 2025
Via The Motley Fool · April 2, 2025
“My mom was dying from cancer and I wanted her off all the medications that were basically killing her,” says Gary Payton, recalling the deeply personal journey that brought him to cannabis.
Via Benzinga · April 2, 2025
Via Benzinga · April 2, 2025
Palantir is poised to win a new U.S. Army contract that could eventually deliver annual recurring revenue approaching $100 million, said a William Blair analyst.
Via Investor's Business Daily · April 2, 2025
The long-run expected total return for the Global Market Index fell again in March, dropping to an annualized 6.9% vs. the previous month’s 7.1%.
Via Talk Markets · April 2, 2025
It's true, the company can sell Lilly's tirzepatide. But that doesn't mean patients will buy it.
Via Investor's Business Daily · April 2, 2025
Via Benzinga · April 2, 2025
Via Benzinga · April 2, 2025
Nintendo on Wednesday officially unveiled its Switch 2 game console, which uses a custom Nvidia processor. The device will launch on June 5.
Via Investor's Business Daily · April 2, 2025
Walmart is negotiating with Chinese suppliers to lower prices by up to 10% to offset new tariffs. Other retailers expect prices to increase.
Via Benzinga · April 2, 2025
Sunshine Biopharma's K1.1 mRNA-LNP shows promise for HCC treatment in mice, while its 2024 revenue surged 45% to $34.9 million.
Via Benzinga · April 2, 2025
Via Benzinga · April 2, 2025
After opening the day on a positive note, Indian benchmark indices sustained their gains throughout the session and ended the day higher.
Via Talk Markets · April 2, 2025
Bitcoin (CRYPTO: BTC) is increasingly popular among corporate buyers, with on-chain data suggesting ongoing accumulation by other
Via Benzinga · April 2, 2025
Macy's announces leadership changes, including CFO and COO exit and new hires. Analyst maintains Market Perform rating, price target of $15.
Via Benzinga · April 2, 2025